Clobazam
- Product NDC
- 0832-0581
- 11-digit product format
- 008320581
- Labeler code
- 0832
- Product ID
- 0832-0581_1e02d082-c325-6bd1-e063-6294a90a14ac
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Clobazam
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Upsher-Smith Laboratories, LLC
- Application
- ANDA209687
- Marketing category
- ANDA
- Marketing start
- 2018-10-22
- Substance
- CLOBAZAM
- Active strength
- 20 mg/1
- Pharmacologic classes
- Benzodiazepine [EPC], Benzodiazepines [CS], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA]
- DEA schedule
- CIV
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Clobazam
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CLOBAZAM | 20 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 2MRO291B4U |
| Rxcui | 199450, 246172 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 0832-0581-11 | Clobazam | 100 in 1 BOTTLE | TABLET | 100 | | 5 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0832-0581 | CLOBAZAM TABLET [UPSHER-SMITH LABORATORIES, LLC] | 5 | Current NDC, Legacy NDC, 1 package rows | 20240725_6da2c381-057b-456a-b57b-464f8b383371.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0832-0581-11 | 00832058111 | 100 TABLET in 1 BOTTLE (0832-0581-11) | 100 tablet | 2018-10-22 | 0000-00-00 | No | No | Current |